Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica
Clinical trial NCT03600818 · TERMINATED
Trial details
- NCT number
- NCT03600818
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2021-05-19
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.